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Introduction
Front–back polarity is a key feature of migrating cells. It is often 
defined as an asymmetric distribution of the microtubule- 
organizing center, the Golgi apparatus, the nucleus, and the 
protrusive activity (Etienne-Manneville and Hall, 2001). Asym-
metry is controlled by different signals, including local activa-
tion of Cdc42 upstream of PKC- (Gomes et al., 2005) as well 
as other Rho GTPases (Hall, 2012). PKC- controls microtubule-
organizing center positioning, and it also localizes to the leading 
edge, forming a complex with Par6, where they jointly regu-
late protrusion (Tan et al., 2008). Among other functions, Rho 
GTPases mediate the asymmetric distribution and activation of 
nonmuscle myosin II (NMII). NMII cross-links and contracts 
actin, promoting linear structures of bundled filaments. NMII 
is a hexamer comprised of two common regulatory light chains, 
two common essential light chains, and two isoform-specific 
heavy chains. Vertebrates express three NMII isoforms as defined 
by the myosin heavy chains, which are encoded in three separate 
genes: Myh9 (NMII-A), Myh10 (NMII-B), and Myh14 (NMII-C). 
Previous studies show that the two major isoforms, NMII-A and 
NMII-B, play fundamentally different roles in the organization 
of the actin in migrating cells (Lo et al., 2004; Even-Ram et al., 
2007; Vicente-Manzanares et al., 2007).
NMII-B determines the rear of migrating cells by localiz-
ing asymmetrically and increasing actomyosin bundling in cells 
on stiff substrates (Vicente-Manzanares et al., 2008) but not 
soft substrates (Raab et al., 2012). The rearward accumulation 
of stable actomyosin bundles inhibits the signals that generate 
protrusions in this region (Vicente-Manzanares et al., 2011). 
Conversely, NMII-A generates minifilaments at the front of the 
cell that promote actin bundling and adhesion maturation be-
hind the lamellipodium (Vicente-Manzanares et al., 2007; Choi 
et al., 2008). NMII-A–generated bundles are thin and dynamic, 
and they can undergo disassembly. NMII-B recruitment to these 
bundles increases their thickness and impairs their disassembly, 
and the adhesions at their ends become elongated and stable 
In this study, we show that the role of nonmuscle myo-sin II (NMII)-B in front–back migratory cell polarity is controlled by a short stretch of amino acids contain-
ing five serines (1935–1941). This motif resides near the 
junction between the C terminus helical and nonhelical 
tail domains. Removal of this motif inhibited NMII-B as-
sembly, whereas its insertion into NMII-A endowed an 
NMII-B–like ability to generate large actomyosin bun-
dles that determine the rear of the cell. Phosphomimetic 
mutation of the five serines also inhibited NMII-B assem-
bly, rendering it unable to support front–back polariza-
tion. Mass spectrometric analysis showed that several of 
these serines are phosphorylated in live cells. Single-site 
mutagenesis showed that serine 1935 is a major regula-
tory site of NMII-B function. These data reveal a novel reg-
ulatory mechanism of NMII in polarized migrating cells 
by identifying a key molecular determinant that confers 
NMII isoform functional specificity.
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Figure 1. The 1935–1941 amino acid region of MHCII-B determines the dynamics of NMII. (A) Alignment of the nonhelical domains of human MHCII-A 
and MHCII-B. Lowercase, last amino acids of the coiled-coil domain. Uppercase, nonhelical tail domain. P in bold is the domain-breaking proline. Shaded 
background, 1935–1941 motif. (B, left column [i]) MHCII-B–depleted CHO.K1 cells expressing GFP (top) and stained for endogenous MHCII-B (bottom). 
(middle and right columns [ii]) MHCII-B–depleted cells expressing shRNA-resistant GFP–MHCII-B (wild type; top row) or GFP–MHCII-B 5S (bottom row). 
(middle column) GFP; (right column) F-actin. Representative examples are shown. (C) Polarity index of MHCII-B–depleted cells rescued or not rescued with 
wild-type or 5S GFP–MHCII-B. Polarity index is calculated as indicated in Materials and methods. Data are the means ± SD of >200 cells from four 
independent experiments; p-value is the significance according to Mann–Whitney’s test. (D) FRAP curves of wild type and 5S GFP–MHCII-B. Data are 
the means ± SEM of 24 individual measurements per condition in four independent experiments. (E–G) Snapshots of TIRF microscopy time-lapse videos of 
MHCII-A–depleted CHO.K1 cells transfected with paxillin-mCherry alone (no rescue; E), or cotransfected with paxillin-mCherry and wild-type GFP–MHCII-A 
(rescue; F) or GFP–MHCII-A+5S (G), plated on fibronectin, and allowed to attach for 45 min. Images were obtained every 5 s. Note the lack of elongated 
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(Vicente-Manzanares et al., 2011). These properties are related 
to the different localization and function of NMII-A and NMII-B 
(Maupin et al., 1994; Kolega, 2003).
Isoform-specific NMII inhibition causes different migra-
tory alterations. NMII-A depletion inhibits rear retraction and 
also impairs adhesion maturation at the front, whereas NMII-B 
depletion inhibits front–back polarization (Lo et al., 2004; Cai 
et al., 2006; Even-Ram et al., 2007; Vicente-Manzanares et al., 
2007). Despite sharing high primary structure homology, the 
isoforms display exquisite functional specificity. Their differ-
ential ability to regulate the component processes of cell migra-
tion resides in the C terminus, nonhelical domain of the heavy 
chains, which mediates oligomerization (Sandquist and Means, 
2008; Vicente-Manzanares et al., 2008). Previous studies of 
NMII-B have revealed that phosphorylations within the coiled-
coil domain of the heavy chain (Li et al., 2006; Clark et al., 2008) 
and the nonhelical chain domain (Rosenberg and Ravid, 2006) 
regulate filament assembly.
In this study, we focus on the role of a group of phosphory-
latable serine (Ser) residues within the nonhelical domain of 
NMII-B in controlling the functions of this isoform. Phospho-
mimetic and nonphosphorylatable mutants together with mass 
spectrometric analysis identify serine 1935 as the major regula-
tory site within this amino acid stretch. Our data demonstrate 
that this motif uniquely controls the ability of NMII-B to gener-
ate stable front–rear polarity and control adhesion dynamics 
in protrusions.
Results and discussion
A Ser-rich motif in the nonhelical domain of 
MHCII-B promotes actomyosin stability and 
cell polarization
The cellular localization and biochemical properties of NMII-A 
and NMII-B depend on the C terminus domain of the myosin 
heavy chain, MHCII (Sandquist and Means, 2008; Vicente- 
Manzanares et al., 2008). To identify unique motifs that determine 
this specificity, we aligned the last 200 amino acids of human 
MHCII-A (NCBI Protein database accession no. NP_002464) 
and MHCII-B (accession no. NP_005955). Whereas the coiled-coil 
portion of both molecules displays high homology (Fig. 1 A, last 
15 amino acids in lowercase and not depicted), the sequences 
diverge significantly beyond Pro1927 (MHCII-A)/Pro1933 
(MHCII-B; Fig. 1 A, uppercase letters). We hypothesized that 
these regions contained unique molecular motifs that control 
the specificity of the cellular function of the isoforms. One such 
motif, a cluster of five serine residues (SFSSSRS) adjacent to 
the domain-splitting Pro in MHCII-B (Fig. 1 A, shaded), ap-
peared particularly interesting, as this motif (1935–1941) is ab-
sent from the analogous region in MHCII-A.
To determine whether the 1935–1941 motif of MHCII-B 
controls the cellular function of NMII-B, we generated a 
GFP-coupled deletion mutant (GFP–MHCII-B 5S). Wild-type 
GFP-coupled MHCII-B rescued the polarity defect induced by 
depletion of endogenous MHCII-B (Fig.1, B and C; Vicente-
Manzanares et al., 2007). In contrast, GFP–MHCII-B 5S was 
unable to restore front–rear migratory polarity (Fig. 1, B and C). 
These cells displayed only small actomyosin bundles and al-
most no large, rear-defining actomyosin bundles (Fig. 1 B, bottom 
right). Similar observations were made in MHCII-B–depleted 
U-2 OS cells, rescued or not with GFP-coupled wild-type or 5S 
MHCII-B (Fig. S1). FRAP analysis of the mutant (as shown in 
Fig. S2 A) revealed an increased fractional recovery compared 
with wild-type MHCII-B, consistent with a decreased stability 
of the mutant in actomyosin bundles (Fig. 1 D). These data indi-
cate that this poly-Ser–containing motif is required for NMII-B 
to generate large bundles that support front–back polarity in 
mesenchymal cells.
To address whether this motif is sufficient to define the 
specific functions of NMII-B in front–rear polarity, we inserted 
the 1935–1941 motif into the analogous position (P+2) of the 
nonhelical domain of MHCII-A (GFP–MHCII-A+5S mutant). 
This insertion produced an NMII-A mutant with properties simi-
lar to NMII-B. Unlike wild-type GFP–MHCII-A (Fig. 1 F and 
Video 2, right), GFP–MHCII-A+5S was not present in protru-
sions, displaying a central subcellular distribution (Fig. 1 G and 
Video 3, right). Furthermore, it did not rescue the adhesion matu-
ration defect observed in cells depleted of endogenous NMII-A 
(Fig. 1 E and Video 1). Adhesion maturation was restored 
by expression of GFP-coupled wild-type MHCII-A (Fig. 1 F  
and Video 2, left) but not of wild-type MHCII-B (Vicente- 
Manzanares et al., 2007). Importantly, GFP–MHCII-A+5S res-
cued the polarity defect induced by depletion of endogenous 
MHCII-B, generating large, rear-defining actomyosin bundles 
(Fig. 1 H and not depicted). FRAP analysis revealed a decreased 
fractional recovery for this mutant when compared with wild-
type MHCII-A (Fig.1 I). These results show that the presence of 
this motif in the nonhelical tail of MHCII, controls the ability of 
NMII to support large and stable actomyosin bundles.
Phosphomimetic analysis reveals that 
phosphorylation of 1935–1941 motif 
regulates the cellular properties of NMII-B
Five of the seven residues of the 1935–1941 motif are serines 
(Fig. 1 A). We hypothesized that these Ser residues regulate the 
cellular function of NMII-B by phosphorylation. To test this, 
we replaced the five Ser with Ala (5×A, nonphosphorylatable) 
or with Asp (5×D, phosphomimetic). Rescue of endogenous 
MHCII-B depletion using the 5×A mutant restored front–back 
polarization to levels comparable to wild-type MHCII-B (Fig. 2, 
A and B). The mutant localized mainly in large bundles defin-
ing the cell sides and its rear (Fig. 2 A). Conversely, the 5×D 
mutant failed to restore front–back polarity, resulting in poorly 
defined actomyosin bundles distributed throughout the cell 
adhesions in protrusions in E and G, and the different distance of the GFP-labeled, wild-type (F), and MHCII-A+5S (G) filaments to the paxillin-decorated 
leading edge. Images extracted from Videos 1–3. (H) Polarity index of MHCII-B–depleted cells rescued or not rescued with the MHCII-A+5S mutant. Data 
are the means ± SD of >200 cells from four independent experiments. (I) FRAP curves of wild-type GFP–MHCII-A and GFP–MHCII-A+5S. Data are the 
means ± SEM of 28 individual measurements per condition in four independent experiments. Bars, 10 µm.
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Figure 2. Phosphomimetic mutation of the five Ser residues adjacent to the nonhelical domain of MHCII-B decreases NMII-B stability and front–back 
polarization. (A) MHCII-B–depleted CHO.K1 cells expressing the indicated shRNA-resistant GFP–MHCII-B mutants. Column on right depicts GFP. (top) 
Wild type; (middle) 5×A; (bottom) 5×D. Left column is F-actin. Note the lack of polarity in the cell rescued with the 5×D mutant. Representative examples 
are shown. Bars, 10 µm. (B) Polarity index of MHCII-B–depleted cells rescued or not rescued with the constructs shown in A. Data are the means ± SD of 
>200 cells from four independent experiments. (C) FRAP curves of the GFP–MHCII-B mutants used in A and B. Data are the means ± SEM of 24 individual 
measurements per condition in four independent experiments.
Table 1. Phosphorylated residues within the nonhelical tail domain of endogenous MHCII-B identified by MS
Residues Sequence Phosphoresidue Screening IMAC
1930–1940 GGPISFSSSR 1935 + +
1929–1940 RGGPISFSSSR 1935 + +
1929–1940 RGGPISFSSSR 1937  +
1930–1940 GGPISFSSSR 1938 + +
1929–1940 RGGPISFSSSR 1938 + +
1930–1940 GGPISFSSSR 1939 + +
1929–1940 RGGPISFSSSR 1939 + +
1930–1940 GGPISFSSSR *  +
1930–1940 RGGPISFSSSR *  +
1958–1976 QLHLEGASLELSDDDTESK 1965  +
1958–1976 QLHLEGASLELSDDDTESK 1969 + +
1958–1976 QLHLEGASLELSDDDTESK 1965 + 1969 + +
Asterisks indicate diphosphorylated forms of the peptide, although the specific combination of phosphorylated sites is not distinguishable from the MS/MS spectra. Plus 
signs denote positive detection of the indicated phosphorylation; minus signs indicates negative (no) detection of the indicated phosphorylation. Bold letters indicate 
the phosphorylated residue that has been positively detected or not detected within each peptide.
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than wild type or the 1935A mutant (Fig. 3 C). Thus, S1935 acts 
as an on/off switch: when dephosphorylated, NMII-B is stable 
and forms large filaments; when phosphorylated, it forms less 
stable filaments.
Among phosphorylatable residues, S1935 is the closest to 
P1933. Phosphorylation of S1935 adds negative charge next to 
the domain-breaking Pro. This may destabilize the coiled-coil 
tail domain, impairing oligomerization and perturbing actomy-
osin bundling. Interestingly, phosphomimetic mutation of all of 
the more distal Ser residues (ADDDD mutant) decreases NMII-B 
filament stability modestly, but not enough to impair cell polar-
ity, suggesting that additional phosphorylations in this motif 
may cooperate with S1935. On the other hand, highly dynamic 
MHCII-A has several positively charged amino acids in this do-
main. Insertion of the 1935–1941 motif of MHCII-B into its 
equivalent position (Pro +2) of MHCII-A increases the stability 
of the filaments (Fig. 1). Conversely, inserting the phosphomi-
metic (+5D) version of the 1935–1941 motif further decreased 
the stability of NMII-A compared with wild-type NMII-A 
(Fig. S2 B), suggesting that net charge in this region is an im-
portant regulator of NMII stability.
Mammalian MHCII-B displays a sequence motif 
(PISFSSSRS) that is well conserved in birds (PITFSSSRS), 
amphibians (PVSFSSSSS), and fish (Danio rerio, PVSFSSSRS; 
Callorhinchus milii, GLTFTSSRT). A similar motif appears 
in zipper, the myosin II equivalent in Drosophila melanogaster 
(GIGLSSSRLT), but is absent in simple multicellular (Cae-
norhabditis elegans) and unicellular organisms, e.g., Dictyostelium 
discoideum and Saccharomyces cerevisiae. This suggests that 
this motif emerges early in evolution to slow down NMII-related 
actomyosin turnover, facilitating the appearance of elaborate 
actin structures required in complex multicellular organisms.
Ser1935 controls the ability of NMII-
B to locally suppress protrusion during 
front–back polarization and regulates its 
positioning outside the leading edge
To address the role of Ser1935 phosphorylation in establishing 
migratory front–back polarization, we observed CHO.K1 cells 
reconstituted with GFP-coupled wild-type MHCII-B or the 1935D 
mutant and an mCherry-labeled adhesion marker (vinculin) using 
total internal reflection fluorescence (TIRF) microscopy. Cells 
reconstituted with the 1935D mutant displayed intermittent 
(Fig. 2, A and B). FRAP analysis showed that the fractional re-
covery of the 5×A mutant was comparable to wild-type MHCII-B, 
whereas it was increased in the 5×D (Fig. 2 C). These data show 
that Ser phosphorylation in this amino acid stretch is a negative 
regulator of NMII-B–dependent actomyosin assembly.
Ser1935 is a central regulatory  
residue that controls NMII-B assembly  
and dynamics
We next sought to determine the contribution of individual Ser 
residues within the 1935–1941 motif to the regulation of NMII-B 
function. To do this, we analyzed the phosphorylation of endog-
enous MHCII-B by mass spectrometry (MS). Three Ser (S1935, 
S1938, and S1939; Table 1 and Fig. S3) were phosphorylated 
with relative abundances ranging from 1–2% (S1935 and S1939) 
to 5–10% (S1938). Phosphorylation of S1937 and peptides con-
taining two phosphorylated Ser were detected only in immobilized 
metal affinity chromatography (IMAC)–enriched preparations 
(see Materials and methods for details; Table 1). These data 
suggest that phosphorylation of S1935 and/or S1938 and/or 
S1939 or a combination of these residues regulates NMII-B. Im-
portantly, S1935 phosphorylation has been reported in HeLa 
cells (Olsen et al., 2010; Zhou et al., 2013) and liver extracts 
(Bian et al., 2014).
We next focused on the specific role of each Ser of the 
1935–1941 motif by generating single phosphomimetic and 
nonphosphorylatable mutants for S1935, S1938, and S1939. 
All the single nonphosphorylatable (S to A) mutants displayed 
FRAP recoveries similar to that of wild-type GFP–MHCII-B 
(Fig. 3 A). Likewise, mutating S1938 or S1939 to Asp (S to D) 
had no significant effect. However, the S1935D mutant displayed 
an elevated fractional recovery (Fig. 3 B). Also, this mutant was 
unable to rescue the depolarized phenotype caused by NMII-B 
depletion in CHO.K1 (Table 2) and the organization of large 
actomyosin filaments in U2OS cells (Fig. S1).
To confirm that Ser1935 is the main regulatory residue in 
this motif, we mutated S1935 to D, the rest of the Ser to A 
(DAAAA), and vice versa (ADDDD). The DAAAA mutant be-
haved like the 1935D mutant, displaying high fractional recov-
ery after photobleaching and an inability to restore polarization 
in MHCII-B–depleted cells (Fig. 3 C and Table 2). In contrast, 
the ADDDD mutant restored cell polarization (Table 2), and 
its fractional recovery after photobleaching was slightly higher 
Table 2. Quantification of the polarity index of the S1935 mutants
Endogenous MHCII-B depletion Rescued with Polarity index ± SD P-value
No (control) N/A 2.23 ± 0.81 <0.01b
Yes No (MHCII-B knockdown) 1.24 ± 0.19 <0.01a
Yes GFP–MHCII-B wild type (rescue) 2.01 ± 0.54 <0.01b
Yes GFP–MHCII-B 1935A 2.06 ± 0.65 <0.01b
Yes GFP–MHCII-B 1935D 1.35 ± 0.29 <0.01a
Yes GFP–MHCII-B ADDDD 1.95 ± 0.73 <0.01b
Yes GFP–MHCII-B DAAAA 1.36 ± 0.32 <0.01a
Data are the quantification of four experiments (number of cells >200/condition). P-value denotes significance according to the Mann–Whitney test. N/A, not 
applicable.
aVersus MHCII-B–depleted cells rescued with GFP–MHCII-B wild type (row 3).
bVersus nonrescued cells (row 2).
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appeared behind an NMII-A–only region immediately poste-
rior to the lamellipodium, the 1935D mutant appeared inter-
spersed with NMII-A and close to the leading edge (Fig. 4 B and 
Fig. S1, arrows). Live-cell confocal imaging experiments showed 
that the 1935D mutant formed numerous puncta within protru-
sions, whereas wild-type MHCII-B puncta seldom localized to 
these regions (Fig. 4 C and Videos 6 and 7). These results sug-
gest that Ser1935 is a crucial regulator of NMII-B assembly and 
dynamics, and its phosphorylation status controls the proper lo-
calization and function of this isoform.
Ser1935 regulates the formation of large 
NMII-B actomyosin bundles and front–rear 
polarity downstream of PKC-
Previous studies showed that PKC- controls cell polarization up-
stream of NMII (Gomes et al., 2005; Even-Faitelson and Ravid, 
2006). To determine whether NMII-B–mediated generation of 
protrusions along the cellular perimeter (Fig. 3 E and Video 5), 
whereas wild type–expressing cells displayed nonprotrusive, 
MHCII-B–containing stable rears (Fig. 3 D and Video 4). Also, 
protrusions in 1935D-expressing cells contained many small adhe-
sions and GFP-labeled NMII filaments that turned over frequently 
(Fig. 3 E and Video 5). Adhesions associated with wild-type 
MHCII-B–decorated filaments remained stable (Fig. 3 D and 
Video 4). These experiments suggest that Ser1935 phosphorylation 
impairs the ability of NMII-B to locally suppress protrusion.
NMII-A forms puncta in protrusive areas, whereas NMII-B 
seldom appears in these regions (Kolega, 2003; Vicente-Manzanares 
et al., 2008). Confocal imaging revealed that GFP–MHCII-B 
1935D was prominently localized to protrusions in CHO.K1 
(Fig. 4 A, bottom row) and U-2 OS cells (Fig. S1, arrows). On 
the contrary, wild-type NMII-B and the 1935A mutant were 
not prominent in these regions (Fig. 4 A, top and middle rows; 
and Fig. S1, arrowheads). Also, whereas wild-type NMII-B 
Figure 3. Ser1935 regulates the stability of NMII-B in actomyosin bundles and controls its ability to locally suppress protrusion during front–back 
polarization. (A) FRAP curves of wild-type and single mutation S1935A, S1938A, and S1939A GFP–MHCII-B constructs. (B) FRAP curves of wild-type 
and single mutation S1935D, S1938D, and S1939D GFP–MHCII-B proteins. (C) FRAP curves of wild-type GFP–MHCII-B and DAAAA and ADDDD 
mutants. (A–C) Data are the means ± SEM of 24 individual measurements per condition in four independent experiments. (D and E) Snapshots of TIRF 
microscopy time-lapse videos of MHCII-B–depleted CHO.K1 cells cotransfected with shRNA-resistant wild-type GFP–MHCII-B (D) or GFP–1935D-MHCII-B (E) 
and mCherry-vinculin. Arrows point to protrusive areas of the cell. Arrowheads point to regions decorated with NMII-B filaments. Bars, 10 µm. Images 
extracted from Videos 4 and 5.
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MHCII-B constructs. Wild-type MHCII-B did not prevent myr–
PKC-–induced loss of polarity. In contrast, the 1935A and 5×A 
mutant prevented this effect (Fig. 5, C and D). Previous studies 
have shown that PKC- phosphorylates MHCII-B in Ser1937 
downstream of Pak1 (Even-Faitelson et al., 2005; Even-Faitelson 
and Ravid, 2006), but the nonphosphorylatable 1937A mutant 
does not overcome the effect of activated PKC- (Fig. 5, C and D). 
large, stable bundles is controlled by PKC-, we expressed a con-
stitutively active mutant PKC- (myristoylated [myr]–PKC-). 
This construct induced isotropic protrusion along the perimeter of 
the cell and prevented the assembly of large and stable, NMII-B– 
decorated actomyosin bundles (Fig. 5, A and B).
To assess the role of Ser1935 in polarization under these con-
ditions, we coexpressed myr–PKC- with various GFP-coupled 
Figure 4. Ser1935 controls the architecture of the leading edge and the exclusion of NMII-B from this region. (A) CHO.K1 cells transfected with the indicated 
GFP-MHCII-B constructs (green in overlay) were plated on fibronectin, allowed to attach for 2 h, treated with IGF-1 for 15 min, fixed, and stained for F-actin 
(magenta in overlay). Representative examples are shown. (B) CHO.K1 cells transfected with the indicated GFP–MHCII-B constructs (green in overlay) were 
treated as in A and stained for F-actin (blue in overlay) and endogenous NMII-A (IIA; red in overlay). endo, endogenous. (C) Snapshots of confocal time-lapse 
videos of wild-type GFP–MHCII-B (top) or the 1935D mutant (bottom). The edge of the cell was obtained from corresponding phase-contrast images. Arrow-
head in the wild-type image indicates a protrusion devoid of small puncta corresponding to wild-type NMII-B; arrows in the NMII-B 1935D image indicate small 
puncta corresponding to the mutant appearing within the protrusion. Bars: (A and C) 10 µm; (B) 5 µm. Images extracted from Videos 6 and 7.
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Figure 5. PKC- controls cell polarity in a Ser1935 MHCII-B–dependent fashion. (A) Representative images display the localization of endogenous MHCII-A 
(top right) and MHCII-B (bottom right) and F-actin. Images are z projections of confocal stacks. (B) Effect of myristoylated (myr; constitutively active) PKC- 
in cell polarity. Cells were transfected with FLAG-tagged wild type (top row) or myr–PKC- (bottom row) and stained for endogenous MHCII-B (middle col-
umn) and F-actin (left column). FLAG staining (right column) denotes transfected cells. Representative cells are shown. (C) Reversion of myr–PKC- induced 
depolarization by NMII-B mutants. Images depict representative cells cotransfected with FLAG-myr–PKC- and the indicated GFP–MHCII-B construct. F-actin 
is shown in the left column, GFP-MHCII-B mutants are in the middle column, and FLAG is shown in the right column. (D) Quantification of the polarity index 
of cells as shown in C. Data are the means ± SD of >200 cells from four independent experiments, and p-value is the significance score in the Mann–Whit-
ney test. Bars, 10 µm.
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Together, this study shows the existence of at least one crucial 
regulatory residue that controls the differential ability of NMII-B 
to form stable actomyosin bundles during cell migration, thereby 
contributing to the stabilization of migratory polarity in mesen-
chymal cells.
Materials and methods
Antibodies and reagents
Antibodies against the following molecules were used: MHCII-A and MHCII-B 
(rabbit IgG; Covance); FLAG (mouse IgG; Sigma-Aldrich). IGF-1, Phalloidin, 
and secondary antibodies (goat IgG against mouse or rabbit) conjugated to 
Alexa Fluor dyes (Alexa Fluor 488, 568, or 647 as indicated) were obtained 
from Invitrogen. Fibronectin and all other reagents were obtained from 
Sigma-Aldrich unless indicated otherwise.
Plasmids
GFP is in the cytomegalovirus (CMV)-based pEGFP-C1. GFP–MHCII-A and -B 
are C-terminal fusions of the corresponding human genes in the CMV-based 
pEGFP-C3 vector. pSUPER–MHCII-A and pSUPER–MHCII-B contain described 
shRNA sequences against the corresponding rat/hamster (MHCII-A) and 
rat/hamster/human (MHCII-B) genes (Vicente-Manzanares et al., 2007). 
Paxillin-mCherry is an N-terminal fusion of chicken paxillin in the CMV-based 
pEGFP-N3 vectors in which EGFP has been replaced with mCherry (Choi 
et al., 2008). mCherry-vinculin was generated from chicken vinculin in the 
CMV-based pEYFP-C1 vector (provided by S. Craig [John Hopkins School 
of Medicine, Baltimore, MD] through Addgene) by fluorescent probe swap 
(from pmCherry-C1). The MHCII-A and MHCII-B mutants were constructed 
from the GFP–MHCII-A or GFP–MHCII-B constructs described in the previous 
sentences by site-directed mutagenesis using the GeneTailor kit (Invitrogen). 
These include GFP–MHCII-B 5S, GFP–MHCII-A+5S, GFP–MHCII-A+5D, 
GFP–MHCII-B 5×A, GFP–MHCII-B 5×D, GFP–MHCII-B 1935A, GFP–MHCII-B 
1935D, GFP–MHCII-B 1937A, GFP–MHCII-B 1938A, GFP–MHCII-B 1938D, 
GFP–MHCII-B 1939A, GFP–MHCII-B 1939D, GFP–MHCII-B ADDDD, and 
GFP–MHCII-B DAAAA. All the human MHCII-B mutants include a silent muta-
tion in the shRNA target sequence (TCA→AGC = Ser→Ser) that renders them 
shRNA insensitive (Vicente-Manzanares et al., 2007). FLAG-tagged rat PKC- 
(wild type and myr) constructs in the pCMV6 vector were obtained from A. 
Toker (Beth Israel Deaconess Medical Center, Boston, MA) through Addgene 
and have been described previously (Chou et al., 1998).
Cell culture and transfection
Chinese hamster ovary CHO.K1 cells (CCL-61; ATCC) were maintained 
in DMEM medium with 1 g/dl (low) glucose and supplemented with 10% 
FBS, 4 mM l-glutamine, 1% nonessential amino acids, and 100 U/ml 
penicillin/streptomycin. Cells were transfected as described previously 
(Vicente-Manzanares et al., 2011) using X-tremeGENE HP (Roche) as indi-
cated by the manufacturer. Analysis was performed 24 h (overexpression) 
or 96 h (depletion and rescue) after transfection. Human osteosarcoma 
U-2 OS cells (HTB-96; ATCC) were maintained in McCoy’s medium supple-
mented with 10% FBS, 4 mM l-glutamine, 1% nonessential amino acids, 
and 100 U/ml penicillin/streptomycin. U-2 OS transfected cells were as-
sayed after 120 h.
Cell plating and immunofluorescence assays
For in vivo as well as staining, cells were allowed to adhere for 1–2 h to 
13-mm glass coverslips coated with 2 µg/ml fibronectin in the presence of 
100 ng/ml IGF-1 for 15 min where indicated. For staining, cells were fixed 
using 4% PFA for 10 min at room temperature, permeabilized with 0.2% Triton 
X-100 for 10 min, and incubated for 2 h with the indicated primary anti-
bodies followed by a 1:500 dilution of the appropriate Alexa Fluor– 
conjugated antibody and/or Alexa Fluor–conjugated phalloidin for 45 min. 
Three rinses of 5 min with TBS were performed between incubations and 
before mounting on glass slides using ProLong antifade medium. Quanti-
fication of the polarity index was performed on images acquired using a 
fluorescence microscope (DMR; Leica). In brief, the polarity index is the 
result of dividing the length of the main migration axis (which denotes the 
direction of migration) by the length of the perpendicular axis that passes 
through the center of the nucleus (Vicente-Manzanares et al., 2007). Polar-
ity index data are always represented as the mean ± SD of >200 cells from 
four independent experiments. These data did not display a normal distri-
bution (according to Shapiro–Wilk’s test); thus, we used Mann–Whitney’s 
test to determine significance.
Confocal and TIRF microscopy
FRAP and in vivo imaging was performed using a confocal microscope (SP5; 
Leica). Images were obtained using a 63× Plan Apochromat objective (NA 
1.40) by illumination with light of the appropriate wavelength from a 488-nm 
Ar laser (fluorochromes used with this laser included GFP or Alexa Fluor 
488 as indicated), 561-nm diode-pumped solid-state laser (fluorochromes 
used with this laser included mCherry or Alexa Fluor 568 as indicated), or a 
633-nm He/Ne laser (fluorochrome used with this laser is Alexa Fluor 647) 
using spectral filtering and hybrid (HyD; Leica) detectors. Images were col-
lected using TCS software (Leica). TIRF images (using GFP- and/or mCherry-
tagged probes) corresponding to Fig. 1 and Videos 1–3 were acquired on 
an inverted microscope (IX70; Olympus) equipped with a 60× Apochromat 
N objective (NA 1.45). Excitation laser lines were 488 and 543 nm. For 
dual GFP-mCherry, a dual emission filter (Z488/561) was used. Images 
were acquired with a charge-coupled device (CCD) camera (Retiga EXi; 
QImaging) and MetaMorph software (Molecular Devices). TIRF images 
(using GFP- and/or mCherry-tagged probes) from Fig. 3 and Videos 4 and 5 
were acquired on an automated inverted microscope (IX83; Olympus) fitted 
with a 60× Apochromat N 60× OTIRF (NA 1.49) objective, a cellTIRF Mitico 
Unit (Olympus), and 491/561-nm laser lines. Dual GFP-mCherry samples 
were visualized with a dual emission filter (Z488/561). Images were cap-
tured using an electron-multiplying CCD camera (ImagEM X2; Hamamatsu 
Photonics) and Xcellence software (Olympus). In all cases, cells were kept 
at 37°C in temperature-controlled incubators. Imaging medium was CCM-1 
(HyClone) or phenol red–free DMEM (Gibco) + 10% FCS. Images were 
analyzed using ImageJ (National Institutes of Health).
FRAP
Confocal images for FRAP analysis were acquired using the confocal mi-
croscope (SP5) as described in the previous section. Initially, a cellular 
area (35 µm2) that contained GFP fusion protein-decorated actin filament 
bundles was scanned three times and then bleached using 30 scans at 
100% laser power. To image the recovery of fluorescence intensity after 
photobleaching, we recorded 15 scans every 0.06 s, 15 scans every 1 s, 
and subsequent scans every 3–5 s. Background subtraction and normaliza-
tion were calculated using built-in algorithms, and normalized intensities 
versus time (seconds) were represented. FRAP data are always represented 
as the means ± SEM of 24 individual measurements per condition in four 
independent experiments.
Mass spectrometry—phosphoproteomics
In brief, HEK-293 cells were and maintained in DMEM medium for 24 h. To 
inhibit phosphatase activity, cells were treated with 1 µM peroxovanadate 
and 10 nM calyculin A (EMD) 30 min before lysis. Subsequently cells were 
lysed in a buffer containing 20 mM Tris, 300 mM NaCl, 10 mM MgCl2, 
and 5 mM ATP with protease and phosphatase inhibitors and immuno-
precipitated for 90 min using 5 µl/sample of the MHCII-B antibody (Covance) 
and 100 µl/sample protein A–conjugated Sepharose (GE Healthcare). The 
samples were rinsed three times with lysis buffer and resuspended in 100 µl 
Laemmli buffer. Samples were separated using 7% SDS-PAGE and stained 
using a commercial silver staining kit. A single band at 230 kD as deter-
mined by comparison to a molecular weight ruler (Bio-Rad Laboratories) 
was excised. The purified protein was reduced, alkylated, and digested in 
gel with trypsin, and peptides were extracted and desalted. A portion of 
the peptide mixture was gradient eluted into on a front-end electron transfer 
dissociation-enabled mass spectrometer (LTQ-FT; Thermo Fisher Scientific). 
MS1 spectra were acquired in the high-resolution Fourier transform mass 
analyzer, and MS2 spectra were acquired in the linear ion trap mass ana-
lyzer. Additionally, the peptide mixture was enriched for phosphopeptides 
using iron-IMAC after conversion of peptide carboxyl groups to methyl 
esters as described elsewhere (Ficarro et al., 2002). In brief, a 150-µm 
inner diameter fused-silica column with 6 cm of POROS MC 20 µm metal 
affinity bulk media (Applied Biosystems) was constructed. The column was 
rinsed with water, 50 mM EDTA, pH 9, and water again. The column was 
activated with 100 mM FeCl3 (Sigma-Aldrich) and then rinsed with 0.01% 
acetic acid at 1 µl/min flow rate. Peptide methyl esters were reconsti-
tuted in a 1:1:1 solution of acetonitrile/methanol/0.01% acetic acid and 
then loaded onto the activated IMAC column at a flow rate of 1 µl/min. 
The column was washed with 1:1:1 solution and 0.01% acetic acid be-
fore being butt connected to a C18 precolumn, as previously described. 
Phosphopeptides were eluted onto the precolumn with 250 mM ascorbic 
acid (Sigma-Aldrich) at 1 µl/min; combined columns were washed with 
0.1% acetic acid at the same flow rate. The IMAC and precolumn were 
separated after which the loaded precolumn was rinsed with 0.1% acetic 
acid before connection to an analytical column. Phosphopeptides were 
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gradient eluted and mass analyzed using the methods described earlier 
in this section. All MS2 spectra were searched against a MHCII-B protein 
database and the human, rat, and mouse NR (nonredundant) database 
using the OMSSA (Open Mass Spectrometry Search Algorithm), and they 
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Online supplemental material
Fig. S1 depicts the morphologies, actin, and MHCII-A/B staining of U-2 OS 
cells depleted of MHCII-B and rescued with the indicated constructs. Fig. S2 
shows a representative FRAP experiment and FRAP of MHCII-A+5D. Fig. S3 
shows collisionally activated dissociation MS/MS spectrum of the endoge-
nous MHCII-B tryptic peptide GGPIsFSSSR phosphorylated on Ser-1935 and 
extracted ion chromatogram of endogenous monophosphorylated MIIB pep-
tide Gly 1931–Arg 1940 with the three different detected phosphorylations. 
Videos 1–3 show adhesion assembly visualized by TIRF in MHCII-A– 
depleted cells using paxillin-mCherry (Video 1 and Videos 2 and 3, left) and 
the dynamics of GFP–MHCII-A wild type (Video 2, right) and the +5S mutant 
(Video 3, right) used for functional rescue. Videos 4 and 5 show adhesion 
assembly visualized by TIRF in MHCII-B–depleted cells with mCherry-vinculin 
(left) and dynamics of GFP–MHCII-B wild type (Video 4, right) and 1935D 
(Video 5, right) used for functional rescue. Videos 6 and 7 show dynamics 
of GFP–MHCII-B wild type (Video 6, left) and 1935D (Video 7, left) and the 
corresponding phase images (right). Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201407059/DC1. Addi-
tional data are available in the JCB DataViewer at http://dx.doi.org/10 
.1083/jcb.201407059.dv.
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